WAI CHUN BIOTEC (00660) releases its interim performance, with a net loss attributable to shareholders of HK$5.939 million, a decrease of 56.53% compared to the same period last year.

WAI CHUN BIOTEC (00660) released its interim results for the six months ended December 31, 2025. The company achieved revenue of HK$352 million, an increase of 118.65% year-on-year. The net loss attributable to the owners of the company for the period was HK$5.939 million, a decrease of 56.53% year-on-year, with a loss per share of 3.33 HK cents. The announcement stated that the increase in revenue was due to an increase in market consumption and demand during the period. The Group's gross profit and gross profit margin for the six months ended December 31, 2025, were approximately HK$35.7 million and 10.1%, respectively. This is an increase of approximately HK$14.5 million and a decrease of 3.0% compared to the gross profit of approximately HK$21.1 million and gross profit margin of approximately 13.1% for the six months ended December 31, 2024.